Targeting MMP-9 in Diabetic Foot Ulcers

Area of Science:

• Biochemistry
• Wound Healing
• Diabetes Complications

Background:

• Diabetic foot ulcers (DFUs) represent a significant unmet medical need in diabetes management.
• Matrix metalloproteinases (MMPs) are implicated in wound healing, but their complex roles and challenges with broad-spectrum inhibitors have hindered DFU treatment.
• Distinguishing active MMPs from inactive forms is crucial for therapeutic targeting.

Purpose of the Study:

• To review the discovery of active MMP-9 as a key factor in non-healing diabetic wounds.
• To explore targeting MMP-9 as a novel therapeutic strategy for DFUs.
• To differentiate the roles of MMP-8 and MMP-9 in diabetic wound healing.

Main Methods:

• Proteomics and batimastat affinity resin were used to identify active MMPs in diabetic wounds.
• Comparative analysis of MMP-8 and MMP-9 activity in mouse and human diabetic wound models.
• Review of preclinical and clinical data on selective MMP-9 inhibitors.

Main Results:

• Active MMP-8 and MMP-9 were identified in both mouse and human diabetic wounds.
• MMP-9 was found to have a detrimental effect on diabetic wound healing.
• MMP-8 demonstrated a beneficial role in the wound healing process.

Conclusions:

• Active MMP-9 is a critical mediator of diabetic wound healing impairment.
• Selective inhibition of MMP-9 presents a promising therapeutic avenue for DFUs.
• Further research into MMP-8's role may offer complementary treatment strategies.